← Back to Screener
Boston Scientific Corp. (BSX)
Price$48.55
Value ScoreC
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-60.13%
Price vs S&P 500 (4W)-9.97%
VGM Score52.06
Market Capitalization$72.16B
P/E Ratio (Annual)24.90x
All Metrics
P/CF (Annual)15.92x
Book Value / Share (Quarterly)$17.40
P/TBV (Annual)8.21x
Revenue Growth (3Y)16.54%
Cash Flow / Share (Quarterly)$2.34
Price vs S&P 500 (YTD)-57.24%
Gross Margin (TTM)69.14%
Net Profit Margin (TTM)17.29%
EPS (TTM)$2.38
10-Day Avg Trading Volume28.05M
EPS Excl Extra (TTM)$2.38
Revenue Growth (5Y)15.16%
EPS (Annual)$1.94
Dividend / Share (Annual)$0.00
ROI (Annual)8.12%
Gross Margin (Annual)69.01%
Net Profit Margin (5Y Avg)10.19%
Cash / Share (Quarterly)$0.98
P/E Basic Excl Extra (TTM)20.24x
Revenue Growth QoQ (YoY)11.58%
P/E Normalized (Annual)24.90x
ROA (Last FY)6.64%
Revenue Growth TTM (YoY)17.44%
EBITD / Share (TTM)$3.15
ROE (5Y Avg)7.79%
Operating Margin (TTM)18.40%
Cash Flow / Share (Annual)$2.47
P/B Ratio2.79x
P/B Ratio (Quarterly)3.61x
Net Income / Employee (Annual)$49,100
EV / Revenue (TTM)3.96x
Net Interest Coverage (TTM)18.54x
ROA (TTM)8.28%
EPS Growth QoQ (YoY)98.56%
EV / EBITDA (TTM)17.38x
EPS Incl Extra (Annual)$1.94
Current Ratio (Annual)1.62x
Quick Ratio (Quarterly)1.14x
3-Month Avg Trading Volume18.75M
52-Week Price Return-52.79%
EV / Free Cash Flow (Annual)22.35x
P/E Incl Extra (TTM)20.24x
Revenue / Employee (TTM)$349,400
Tangible BV / Share (Quarterly)$12.65
P/S Ratio (Annual)3.59x
Asset Turnover (Annual)0.46x
52-Week High$109.50
Operating Margin (5Y Avg)14.58%
EPS Excl Extra (Annual)$1.94
CapEx CAGR (5Y)10.91%
Tangible BV CAGR (5Y)12.84%
26-Week Price Return-52.21%
Quick Ratio (Annual)1.02x
13-Week Price Return-33.48%
Total Debt / Equity (Annual)0.47x
Current Ratio (Quarterly)1.90x
Enterprise Value$81.74B
Revenue / Share Growth (5Y)13.93%
Asset Turnover (TTM)0.48x
Book Value / Share Growth (5Y)8.60%
Revenue / Employee (Annual)$340,200
Inventory Turnover (Annual)2.16x
Pretax Margin (Annual)16.86%
Cash / Share (Annual)$1.32
3-Month Return Std Dev46.29%
Gross Margin (5Y Avg)69.08%
Net Income / Employee (TTM)$60,400
EBITDA CAGR (5Y)44.78%
EBITDA Interim CAGR (5Y)19.15%
ROE (Last FY)11.96%
Net Interest Coverage (Annual)10.85x
EPS Basic Excl Extra (Annual)$1.94
P/FCF (TTM)20.78x
Receivables Turnover (TTM)7.21x
EV / Free Cash Flow (TTM)23.54x
Total Debt / Equity (Quarterly)0.43x
EPS Incl Extra (TTM)$2.38
Receivables Turnover (Annual)7.32x
ROI (TTM)10.07%
P/S Ratio (TTM)3.50x
Pretax Margin (5Y Avg)12.50%
Revenue / Share (Annual)$13.43
Tangible BV / Share (Annual)$11.61
Forward P/E14.42x
Free OCF CAGR (5Y)29.98%
Price vs S&P 500 (52W)-77.15%
P/E Ratio (TTM)20.24x
EPS Growth TTM (YoY)74.72%
Year-to-Date Return-49.08%
5-Day Price Return1.19%
EPS Normalized (Annual)$1.94
ROA (5Y Avg)4.25%
Net Profit Margin (Annual)14.44%
Month-to-Date Return0.50%
Cash Flow / Share (TTM)$1.63
EBITD / Share (Annual)$3.02
EPS Growth (3Y)58.74%
Operating Margin (Annual)18.00%
LT Debt / Equity (Annual)0.46x
P/CF (TTM)16.63x
ROI (5Y Avg)5.22%
P/E Excl Extra (TTM)20.24x
LT Debt / Equity (Quarterly)0.42x
EPS Basic Excl Extra (TTM)$2.38
P/TBV (Quarterly)4.96x
P/B Ratio (Annual)5.83x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.13x
Pretax Margin (TTM)18.15%
Book Value / Share (Annual)$16.34
Price vs S&P 500 (13W)-41.74%
Dividend Yield (TTM)0.00%
Beta0.55x
P/FCF (Annual)19.73x
Revenue / Share (TTM)$13.79
ROE (TTM)14.87%
52-Week Low$47.16
vGradeC
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.80est. 0.79
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.28
4.24
4.20
4.10
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BSXBoston Scientific Corp. | C | B | D | $48.55 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
| GMEDGLOBUS MEDICAL INC | B | A | C | $80.00 |
About
Boston Scientific manufactures minimally invasive medical devices for interventional procedures across cardiac rhythm management, interventional oncology, neuromodulation, and diagnostic imaging applications. The company serves healthcare institutions globally, with approximately 36% of revenues generated internationally.